Avita Medical Half-Year Financial Report for Fiscal 2019
Valencia, Calif., USA, and Melbourne, Australia, 28 February 2019 — AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, announced that it filed today with the ASX its Appendix 4D – Half-Year Report for the six months ended 31 December 2018. Revenues for First Six Months and Update on U.S. National Market Launch […]
